Access cutting-edge kidney transplant treatment through this clinical trial at a research site in Boston. Study-provided care at no cost to qualified participants.
Access kidney transplant specialists in Boston at no cost
This study follows strict safety protocols and ethical guidelines
All study-related kidney transplant treatment provided free
The purpose of this study is to evaluate the benefits and risks of conversion of existing adolescent kidney allograft recipients aged 12 to less than 18 years of age to a belatacept-based immunosuppressive regimen as compared to continuation of a calcineurin inhibitor-based regimen and their adherence to immunosuppressive medications.
Sponsor: Bristol-Myers Squibb
Check if you qualify for this kidney transplant clinical trial in Boston, MA
If you're searching for kidney transplant treatment options in Boston, MA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Boston research site is actively enrolling participants for this clinical trial. You'll receive care from experienced kidney transplant specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.